How much does a box of giritinib fumarate targeted drug cost?

Gilitinib fumarate (Gilteritinib) is a targeted anti-cancer drug targeting FLT3 gene mutations. It is currently on the market in China, but has not yet been included in the medical insurance system. This means that patients may have difficulty purchasing the drug in domestic hospitals and the price burden will be heavy. Since it is not covered by medical insurance, many patients choose to obtain giritinib through overseas channels to meet their treatment needs.

In the international market, there are two main versions of giritinib available: original drugs and generic drugs. The original medicine includes two specifications: the European version and the Hong Kong version. The Hong Kong version is particularly expensive, with a box of medicine priced at around 100,000 yuan. This high price puts many patients under greater financial pressure, limiting the popular use of the drug.

In contrast, the generic version of giritinib is much more affordable, especially the generic version produced in Laos that attracts more attention. The price of the Lao version of giritinib ranges from about one thousand to more than two thousand yuan, with a significant price gap, providing patients with a more affordable option. The ingredients of these generic drugs are basically the same as those of the original drugs, ensuring the effectiveness and safety of the treatment.
Overall, the market price of giritinib fumarate varies greatly. Although original drugs are expensive, the emergence of generic drugs has greatly eased the financial burden on patients. When choosing, patients should reasonably choose a suitable version of the drug based on their own situation and doctor's advice to ensure treatment effect and medication safety.
Reference: https://www.xospata.com/